K24 CA121990-03/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2008	14
2009	4
2010	5
2011	2
2024	0

1

Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study.

Fizazi K, Carducci M, Smith M, Damião R, Brown J, Karsh L, Milecki P, Shore N, Rader M, Wang H, Jiang Q, Tadros S, Dansey R, Goessl C. Fizazi K, et al. Lancet. 2011 Mar 5;377(9768):813-22. doi: 10.1016/S0140-6736(10)62344-6. Epub 2011 Feb 25. Lancet. 2011. PMID: 21353695 Free PMC article. Clinical Trial.

2

Bone health and prostate cancer.

Saylor PJ, Smith MR. Saylor PJ, et al. Prostate Cancer Prostatic Dis. 2010 Mar;13(1):20-7. doi: 10.1038/pcan.2009.50. Epub 2009 Nov 10. Prostate Cancer Prostatic Dis. 2010. PMID: 19901958 Free PMC article. Review.

3

Management of complications of prostate cancer treatment.

Michaelson MD, Cotter SE, Gargollo PC, Zietman AL, Dahl DM, Smith MR. Michaelson MD, et al. CA Cancer J Clin. 2008 Jul-Aug;58(4):196-213. doi: 10.3322/CA.2008.0002. Epub 2008 May 23. CA Cancer J Clin. 2008. PMID: 18502900 Free PMC article. Review.

4

Osteoclast targeted therapy for prostate cancer: bisphosphonates and beyond.

Smith MR. Smith MR. Urol Oncol. 2008 Jul-Aug;26(4):420-5. doi: 10.1016/j.urolonc.2007.11.004. Urol Oncol. 2008. PMID: 18593621 Free PMC article. Review.

5

Bone markers and their prognostic value in metastatic bone disease: clinical evidence and future directions.

Coleman R, Brown J, Terpos E, Lipton A, Smith MR, Cook R, Major P. Coleman R, et al. Cancer Treat Rev. 2008 Nov;34(7):629-39. doi: 10.1016/j.ctrv.2008.05.001. Epub 2008 Jun 24. Cancer Treat Rev. 2008. PMID: 18579314 Free PMC article. Review.

6

Rapid testosterone cycling and chemotherapy for prostate cancer: a way forward or return to the past?

Smith MR. Smith MR. J Clin Oncol. 2008 Jun 20;26(18):2932-3. doi: 10.1200/JCO.2008.16.0788. J Clin Oncol. 2008. PMID: 18565878 No abstract available.

7

Androgen deprivation therapy and risk for diabetes and cardiovascular disease in prostate cancer survivors.

Smith MR. Smith MR. Curr Urol Rep. 2008 May;9(3):197-202. doi: 10.1007/s11934-008-0035-y. Curr Urol Rep. 2008. PMID: 18765113 Free PMC article. Review.

8

Treatment-related diabetes and cardiovascular disease in prostate cancer survivors.

Smith MR. Smith MR. Ann Oncol. 2008 Sep;19 Suppl 7(Suppl 7):vii86-90. doi: 10.1093/annonc/mdn458. Ann Oncol. 2008. PMID: 18790986 Free PMC article. Review. No abstract available.

9

Prospective study of depression and fatigue in men with advanced prostate cancer receiving hormone therapy.

Pirl WF, Greer JA, Goode M, Smith MR. Pirl WF, et al. Psychooncology. 2008 Feb;17(2):148-53. doi: 10.1002/pon.1206. Psychooncology. 2008. PMID: 17443645 Free PMC article. Clinical Trial.

10

Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31.

Efstathiou JA, Bae K, Shipley WU, Hanks GE, Pilepich MV, Sandler HM, Smith MR. Efstathiou JA, et al. J Clin Oncol. 2009 Jan 1;27(1):92-9. doi: 10.1200/JCO.2007.12.3752. Epub 2008 Dec 1. J Clin Oncol. 2009. PMID: 19047297 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

22 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year